[{"data":1,"prerenderedAt":176},["ShallowReactive",2],{"drug-norethindrone":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":23,"regimens":38,"contraindications":80,"warnings":90,"renal":91,"monitoring":92,"interactions":93,"review":94,"examples":97,"atc":107,"iran":109,"links":121,"populations":143,"usApproval":171},"norethindrone",1,{"fa":7,"en":8},"نورتیندرون استات","Norethindrone acetate","genitourinary-sex-hormones",{"fa":11,"en":12},"پروژستین","Progestin",[14],{"name":15,"market":16},"Aygestin","US",[18,19,20,21,22],"aygestin","primolut n","پریمولوت","نورتیندرون","نورتیسترون",[24],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":33,"refs":34},"tab-5","tablet","oral","5 mg tablet (scored)",{"amount":30,"unit":31,"perUnit":26,"scored":32},5,"mg",true,[16],[35],{"source":36,"section":37},"fda-norethindrone","How Supplied",[39,56],{"id":40,"disease":41,"label":42,"population":45,"type":49,"unit":31,"dose":50,"refs":52,"durationDays":55},"aub","abnormal-uterine-bleeding",{"fa":43,"en":44},"آمنوره ثانویه یا خونریزی غیرطبیعی رحم — ۲٫۵ تا ۱۰ mg روزانه ۵ تا ۱۰ روز","Secondary amenorrhoea or abnormal uterine bleeding — 2.5–10 mg daily for 5–10 days",{"minAge":46},{"value":47,"unit":48},12,"year","fixed",{"perDose":30,"perDoseMax":51,"dosesPerDay":5},10,[53],{"source":36,"section":54},"Dosage and Administration",{"min":30,"max":51},{"id":57,"disease":58,"label":59,"population":62,"type":65,"unit":31,"dose":66,"refs":71,"notes":73},"endo","endometriosis",{"fa":60,"en":61},"اندومتریوز — شروع ۵ mg روزانه ۲ هفته","Endometriosis — start 5 mg daily for 2 weeks",{"minAge":63},{"value":64,"unit":48},18,"titration",{"dividedDoses":5,"titration":67},{"start":30,"increment":68,"incrementEveryDays":69,"targetMin":70,"targetMax":70,"max":70},2.5,14,15,[72],{"source":36,"section":54},[74],{"text":75,"refs":78},{"fa":76,"en":77},"هر ۲ هفته ۲٫۵ mg افزایش تا ۱۵ mg\u002Fday؛ این دوز ۶ تا ۹ ماه قابل ادامه است.","Increase by 2.5 mg\u002Fday every 2 weeks to 15 mg\u002Fday; may continue 6–9 months.",[79],{"source":36,"section":54},[81],{"id":82,"severity":83,"text":84,"refs":87},"ci","block",{"fa":85,"en":86},"بارداری؛ خونریزی واژینال تشخیص‌داده‌نشده؛ سرطان پستان؛ DVT\u002FPE فعال یا سابقه (و سایر موارد).","Pregnancy; undiagnosed vaginal bleeding; breast cancer; active or past DVT\u002FPE (and others).",[88],{"source":36,"section":89},"Contraindications",[],[],[],[],{"status":95,"reviewer":96,"date":96},"unverified",null,[98,103],{"regimen":40,"formulation":25,"input":99,"expect":102},{"ageYears":100,"weightKg":101},25,60,{"perDose":30,"upperPerDose":51},{"regimen":57,"formulation":25,"input":104,"expect":106},{"ageYears":105,"weightKg":101},30,{"perDose":30},[108],"G03DC02",{"status":110,"forms":111,"refs":116},"registered",[112],{"code":113,"en":114,"fa":115},"11928","NORETHISTERONE 350MG TAB","قرص نورتیسترون ۳۵۰ میلی‌گرم",[117],{"source":118,"section":119,"url":120},"darooyab-generic","G-3289\u002FNorethisterone","https:\u002F\u002Fwww.darooyab.ir\u002FG-3289\u002FNorethisterone",[122,126,130,134,137,140],{"kind":123,"url":124,"label":125},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=091090","ANDA091090",{"kind":127,"url":128,"label":129},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=d0a94321-eb60-4aa6-a429-f0156f9f8e01","FDA Norethindrone",{"kind":131,"url":132,"label":133},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa601050.html","Ethinyl Estradiol and Norethindrone (Oral Contraceptives)",{"kind":131,"url":135,"label":136},"https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa604034.html","Norethindrone",{"kind":138,"url":139,"label":108},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=G03DC02",{"kind":141,"url":120,"label":142},"darooyab","Norethisterone",{"pregnancy":144,"lactation":153,"pediatric":162},{"level":145,"text":146,"quote":149,"refs":150},"contraindicated",{"fa":147,"en":148},"برچسب: در بارداری منع مصرف دارد.","Label: contraindicated in pregnancy.","• Known or suspected pregnancy.",[151],{"source":36,"section":152},"CONTRAINDICATIONS",{"level":154,"text":155,"quote":158,"refs":159},"caution",{"fa":156,"en":157},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Caution should be exercised when progestins are administered to a nursing woman. 7.",[160],{"source":36,"section":161},"Precautions\u002FWarnings – Nursing Mothers",{"level":163,"text":164,"quote":167,"refs":168},"not-established",{"fa":165,"en":166},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Norethindrone acetate tablets are not indicated in children.",[169],{"source":36,"section":170},"Precautions\u002FWarnings – Pediatric Use",{"kind":172,"refs":173,"id":125},"ANDA",[174],{"source":36,"section":175},"SPL approval \u002F marketing category",1792444704584]